Quality worldwide reach for clinical trial supply services with clientpharma.com
Sources and supplies commercial drug product for global clinical trials today: We’re a specialist pharmaceutical supply company meeting global client requirements for clinical development. ClientPharma offers innovative sourcing and supply solutions from pre-clinical through to Phases I, II and III. Throughout the lifecycle of your drug development, it is our strategic approach that provides effective, tailored solutions that streamline the many complexities, avoiding supply chain disruptions and costly delays. Find additional details at https://www.clientpharma.com/risk-mitigation-and-competitiveness/.
We profoundly understand and recognize the numerous risks associated with global drug procurement. We also appreciate the many complexities associated with worldwide storage and distribution of clinical trial supplies. Our team knows the importance of an efficient, robust supply chain — audited & approved — that promotes excellence, security and accountability. We provide batch traceability, supporting documentation (i.e. Certificates of Analysis (CofAs), Batch Release Certificates (BRCs), GMP Statements, stability data, Fit-for-Use (FFU) Statements, Certificates of Conformance (CofCs), Certificates of Origin (CofOs), etc.) and temperature monitoring data – delivering product pedigree and authenticity.
Supplying the world’s most respected biopharmaceutical companies – ClientPharma handles the numerous challenges of obtaining medicines quickly, in multiple lots, with ranging expiry dating – and we can source and supply from any region in the world! Our deep understanding and skill gives you the visibility needed to fulfill your clinical trial project requirements: Proactive market research and insights Procurement planning services; Worldwide sourcing capabilities; Collection and collation of multiple batches; Provision of batch documentation; Extensive experience and knowledge of emerging markets.
On May 20th, we celebrate International Clinical Trials Day 2023. It is a day to reflect on the ground-breaking work and significant contributions of clinical trials in advancing medical research, improving patient care and transforming lives worldwide. Our heartfelt gratitude goes out to the patients participating in clinical trials and we extend our appreciation to all those that make the clinical trials possible; the researchers, physicians, nurses, and healthcare professionals, with their unwavering dedication to bring new and innovative treatments to those in need. Together we can shape the future of medicine and make a lasting impact on the lives of millions. Happy International Clinical Trials Day! Discover more info on https://www.clientpharma.com/.
Meeting the needs of global clinical supply trials requires diversity in supply strategies to address the unique complexities of each country’s healthcare and medication distribution systems. The “one-size fits all” approach is not a single supply strategy; instead, it leverages the expertise of a supply vendor partnership that addresses the need for a multi-faceted supply chain strategy. ClientPharma (CP) is a specialist global clinical trial supply company providing expertise in the procurement of comparators, rescue medications, adjuvant therapies, standard-of-care, reference drugs, medical devices, ancillaries, and matching placebos. From provision of clinical research samples to bulk supplies for global pivotal trials, the company has built a strong worldwide network to provide strategic commercial drug supply solutions for all stages of clinical programs. Reducing complexity and maximizing value – that’s our mission. CP is headquartered in the United Kingdom with offices and warehousing in the US, Ireland, Belgium, and China.
When volatility of the market is coupled with the increasing complexity of the manufacturing process it creates a new drive for manufacturing solutions. Recently, pharmaceutical companies have begun to move away from conventional forms of manufacturing to use more flexible and modular models. These models are said to increase capacity, reduce costs and decrease development time in clinical trials. Flexibility in the manufacturing process also means that capacity for a drug can be scaled down to accommodate variability and volatility in the market. This can in turn reduce inaccurate estimates when supplying new medicines. Using this model, clients can then increase and decrease orders as and when they need to rather than bulk buying and ending up with surplus. In addition to these new approaches, disposable equipment has also become a major solution. Components such as hoses and bags are swapped over during the process, meaning that production never needs to stop. Although these approaches are often seen as more costly than traditional methods in the first instance, their benefits often out way their risks by creating a more flexible process.